Research

Alzheimer's biomarker test

An Alzheimer's biomarker test looks for the biological changes associated with the disease rather than relying on symptoms alone. The markers of interest are amyloid and tau proteins, measured in cerebrospinal fluid, on specialised imaging or, more recently, in blood. A biomarker result is one input to a diagnosis, not the diagnosis itself.

Quick answer

An Alzheimer's biomarker test looks for the biological changes associated with the disease rather than relying on symptoms alone. The markers of interest are amyloid and tau proteins, measured in cerebrospinal fluid, on specialised imaging or, more recently, in blood. A biomarker result is one input to a diagnosis, not the diagnosis itself.

What a biomarker actually is

A biomarker is a measurable biological signal. In Alzheimer's disease the established ones relate to amyloid plaques and tau tangles, the two protein changes that define the disease pathologically. Detecting them shifts the assessment from describing symptoms to observing the underlying biology, which matters because several other conditions produce similar memory complaints.

How they are measured

Cerebrospinal fluid analysis via lumbar puncture has the longest track record. Specialised PET imaging can show amyloid or tau directly. Blood-based markers are the newest route and the most practical, and their role in routine care is still settling. None of these is performed at the CNS offices: lumbar puncture and PET are arranged elsewhere, and blood draws go to a laboratory.

Why the result needs context

Biomarker changes can be present in people without symptoms, and memory problems can have causes that have nothing to do with amyloid, including thyroid disease, vitamin deficiency, sleep apnoea, depression and medication effects. A biomarker result is interpreted alongside a cognitive assessment and a search for reversible causes, not in place of them.

About this practice

Clinical Neurology Specialists has been physician-owned since 1998, when Leo Germin, M.D., FAANEM founded it. Five board-certified neurologists and four advanced practice providers see patients at the Las Vegas and Henderson offices, each with its own AANEM-accredited electrodiagnostic laboratory.

Clinical Neurology Specialists is an adult outpatient neurology practice for patients 18 and older. The practice performs no surgery and operates no imaging suite, infusion suite or interventional pain programme, and provides no emergency or inpatient care.

MRI, CT, carotid ultrasound and lumbar puncture are not performed at these offices. They are arranged at an imaging centre or hospital, and the report is reviewed with you by the neurologist who ordered it.

Emergency & crisis resources: Clinical Neurology Specialists is not an emergency service. For stroke symptoms, a seizure lasting more than five minutes or any medical emergency, call 911 or go to the nearest emergency room. For a mental health crisis, call or text 988 (Suicide & Crisis Lifeline).

Frequently asked

Questions about alzheimer's biomarker test

What is an Alzheimer's biomarker test?
A test that looks for the biological changes linked to Alzheimer's disease rather than judging by symptoms alone. The markers are amyloid and tau proteins, measured in cerebrospinal fluid, on specialised PET imaging, or in blood. None of these tests is performed at the CNS offices; they are arranged externally and the result is interpreted here alongside the rest of the assessment.
How is memory loss evaluated at CNS?
With a history that includes an account from someone who knows you well, a cognitive assessment, an examination, and a search for reversible contributors such as thyroid disease, vitamin deficiency, sleep disorders, depression and medication effects. Biomarker testing, when appropriate, is arranged externally and interpreted here.
When should I ask about biomarker testing?
When memory or thinking changes are affecting daily life and a specific diagnosis would change decisions about treatment, planning or research participation. It is not a screening test for people without symptoms, and it is not the first step. If the answer would not change any decision you or your family face, that is a legitimate reason to defer it.
Is CNS involved in Alzheimer's research?
Yes. The practice is a research partner of the GAP Foundation, which means some patients may be eligible to take part in studies. Eligibility depends on the specific study and is discussed individually rather than assumed. Taking part is voluntary and separate from your clinical care, so declining changes nothing about the treatment you receive.
Does a positive biomarker mean I will develop dementia?
Not necessarily, and this is one of the harder parts of the conversation. Biomarker changes can be present in people who have no symptoms and who may never develop them on a timescale that matters to them. That uncertainty is exactly why the result is interpreted in context.

Physician-reviewed. Reviewed by the physicians of Clinical Neurology Specialists — board-certified neurologists, AANEM-accredited electrodiagnostic laboratories, physician-owned since 1998. Reviewed 1 August 2026. This article is general education for adults 18 and older and is not a substitute for a consultation.

Next step

Speak to a board-certified neurologist

Adults 18 and older, at the Las Vegas and Henderson offices. Call 702-804-1212 or request an appointment online.